Cardiovascular Drugs Market Research Report, Growth & Forecast

Dilated Cardiomyopathy Therapeutics Market Size & Industry Outlook The global dilated cardiomyopathy therapeutics market size reached US$ 355.54 Million in 2024 from US$ 342.76 Million in 2023 and is...

Dyslipidemia Market Size Dyslipidemia Market Size reached US$16.03 Billion in 2024 and is expected to reach US$40.33 Billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033, a...

Pulmonary Arterial Hypertension Market Size & Industry Outlook The global pulmonary arterial hypertension market size reached US$ 8.04 Billion in 2024 from US$ 7.59 Billion in 2023 and is expected to...

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size The global transthyretin amyloid cardiomyopathy (ATTR-CM) was valued at US$ 2.92 Billion n 2023. The global transthyretin amyloid cardiomyopa...

India Atorvastatin Market was valued at USD 82.42 Million in 2024 and is expected to reach USD 127.25 Million by 2030, growing with a CAGR of 7.65% in the forecast period. The India Atorvastatin Marke...

The global Fondaparinux Sodium Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market...

The Deep Vein Thrombosis (DVT) – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. T...

The Pulmonary Embolism – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The repor...

The global antihypertensive drugs market size was valued at USD 30.45 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 38.41 Billion by 2033, exhibiting a CAGR of 2.6% d...

The global telmisartan market size reached USD 3.83 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.82 Billion by 2033, exhibiting a growth rate (CAGR) of 2.59% during...

Market Overview Global Thoracic Aortic Aneurysm Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 7.61 Billion by 2030 with a CAGR of 4.77%. This is driven by increasing prev...

Dyslipidemia Market reached US$16.03 Billion in 2024 and is expected to reach US$40.33 Billion by 2033, growing with a CAGR of 10.90% during the forecast period 2026-2033. The Dyslipidemia Market emer...

Thoracic Aortic Aneurysm Market The global thoracic aortic aneurysm market size was estimated at USD 1.65 billion in 2024 and is projected to reach USD 5.04 billion by 2033, growing at a CAGR of 13.36...

The Ace Inhibitors Market size is valued at USD 9.3 billion in 2025 and is projected to reach USD 12.9 billion by 2033, registering a compound annual growth rate (CAGR) of 4.17% over the forecast peri...

The Calcium Channel Blocker Market size is valued at USD 14.3 billion in 2025 and is projected to reach USD 23.4 billion by 2033, registering a compound annual growth rate (CAGR) of 6.37% over the for...

The global statin market size reached USD 15.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.3 Billion by 2033, exhibiting a growth rate (CAGR) of 2.74% during 2025-...

The global ischemic heart disease (IHD) drugs market size reached USD 6.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2033, exhibiting a growth rate (C...

The Global Pericarditis Drugs Market was valued at USD 4.1 billion in 2024 and is estimated to grow at a CAGR of 6.2% to reach USD 7.4 billion by 2034. Rising cardiovascular disease rates across the g...

This report can be delivered to the clients within 3 Business Days Eliquis (Apixaban) Market The global Eliquis (apixaban) market size was estimated at USD 20.70 billion in 2024 and is projected to...

This report can be delivered to the clients within 3 Business Days Peripheral Artery Disease Market The global peripheral artery disease market size was estimated at USD 7.3 billion in 2024 and is p...

Acute Myocardial Infarction Market reached US$ 1,790.79 million in 2024 and is expected to reach US$ 3,065.81 million by 2033, growing with a CAGR of 6.70% during the forecast period 2026-2033. The Ac...

According to Stratistics MRC, the Global Eisenmenger Complex Management Market is accounted for $1.36 billion in 2025 and is expected to reach $2.82 billion by 2032 growing at a CAGR of 11.0% during t...

ANGPTL3-Lowering Therapy Market reached US$ 99.75 Million in 2024 and is expected to reach US$ 1,096.42Million by 2033, growing with a CAGR of 30.93% during the forecast period 2026-2033. The ANGPTL3-...

PCSK9 Inhibitor Market reached US$ 1.96 Billion in 2024 and is expected to reach US$ 7.67 Billion by 2033, growing with a CAGR of 16.50% during the forecast period 2026-2033. The PCSK9 Inhibitor Marke...

According to Stratistics MRC, the Global Atrial Fibrillation Market is accounted for $17.6 billion in 2025 and is expected to reach $27.3 billion by 2032 growing at a CAGR of 6.5% during the forecast...

According to Stratistics MRC, the Global Acute Ischemic Stroke Diagnosis and Treatment Market is accounted for $6.4 billion in 2025 and is expected to reach $11.1 billion by 2032 growing at a CAGR of...

Renin-Inhibitors Marketis is growing with a CAGR of 6.70% during the forecast period 2026-2035. The Renin-Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...

Acute Coronary Syndrome Market reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing with a CAGR of 5.10% during the forecast period 2026-2031. The Acute Coronar...

Homozygous Familial Hypercholesterolemia Marketis is growing with a CAGR of 2.50% during the forecast period 2026-2035. The Homozygous Familial Hypercholesterolemia Market emerges as a key focus in Da...

Atrial Fibrillation Market reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing with a CAGR of 10.60% during the forecast period 2026-2033. The Atrial Fibrilla...

Antiplatelet Drugs Market reached US$ 2,705.81 million in 2024 and is expected to reach US$ 5.056.03 million by 2032, growing with a CAGR of 8.20% during the forecast period 2026-2032. The Antiplatele...

The Glycerin Trinitrate Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...

Varicose Veins Treatment Marketis is growing with a CAGR of 4.60% during the forecast period 2026-2035. The Varicose Veins Treatment Market emerges as a key focus in DataM Intelligence latest in-dept...

Atherosclerosis Drugs Market reached US$ 26.4 billion in 2023 and is expected to reach US$ 32.5 billion by 2031, growing with a CAGR of 2.60% during the forecast period 2026-2031. The Atherosclerosis...

The Familial Hypercholesterolemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fores...

The Angiotensin II Receptor Blockers Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...

The Hypertrophic Cardiomyopathy Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fore...

Pericarditis Drugs Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Pericarditis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...

The global antihyperlipidemic drugs market size reached US$ 12.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2032, exhibiting a growth rate (CAGR) of...

Calcium Channel Blocker Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035. The Calcium Channel Blocker Market emerges as a key focus in DataM Intelligence latest in-depth a...

The Lipid-regulating Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...

Treprostinil Drugs Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Treprostinil Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...

The Pericarditis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...

Angina Pectoris Drugs Marketis is growing with a CAGR of 3.00% during the forecast period 2026-2035. The Angina Pectoris Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analy...

The Proprotein Convertase Subtilisin/Kexin Type 9 Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic...

The Lipid Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...

The Myocardial Infarction Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...

The Angiotensin-Converting Enzyme (ACE) Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategi...

The Hypertriglyceridemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...